P. Marpicati
Impact in
-
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Cancer Diagnosis and Treatment
Papers in
- Oncology 23
- Cancer Treatment and Pharmacology 15
- Colorectal Cancer Treatments and Studies 10
-
- Lung Cancer Treatments and Mutations 4
- Gastric Cancer Management and Outcomes 3
- Advanced Breast Cancer Therapies 2
- Co-authors
- Giovanni Marini (31 shared papers)Edda Simoncini (27 shared papers)Vittorio Ferrari (15 shared papers)G. Rangoni (13 shared papers)Lucia Vassalli (13 shared papers)Vito Amoroso (13 shared papers)Francesca Valcamonico (13 shared papers)Alberto Zaniboni (12 shared papers)
In The Last Decade
P. Marpicati
35 papers receiving 281 citations
Peers
Comparison fields: 5 of 48
- Oncology 155
- Cancer Research 50
- Pulmonary and Respiratory Medicine 79
- Hepatology 18
- Pathology and Forensic Medicine 34
Countries citing papers authored by P. Marpicati
This map shows the geographic impact of P. Marpicati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Marpicati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Marpicati more than expected).
Fields of papers citing papers by P. Marpicati
This network shows the impact of papers produced by P. Marpicati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Marpicati. The network helps show where P. Marpicati may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Marpicati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 60 | |
| 2 | 2008 | 32 | |
| 3 | 2001 | 27 | |
| 4 | 1993 | 17 | |
| 5 | 2007 | 14 | |
| 6 | 1988 | 12 | |
| 7 | Treatment of advanced breast cancer with 5-fluorouracil and high-dose folinic acid: preliminary results. | 1985 | 12 |
| 8 | 1989 | 11 | |
| 9 | Cyclophosphamide, epirubicin and cisplatin (CEP) in advanced breast cancer: preliminary results. | 1987 | 9 |
| 10 | 2004 | 8 | |
| 11 | 2005 | 7 | |
| 12 | 1995 | 6 | |
| 13 | 1993 | 6 | |
| 14 | 1989 | 6 | |
| 15 | 1991 | 5 | |
| 16 | 2005 | 5 | |
| 17 | Peptichemio, teniposide and high-dose dexamethasone: a new active combination for relapsing and refractory multiple myeloma. A pilot study. | 1988 | 5 |
| 18 | 2004 | 4 | |
| 19 | 1989 | 4 | |
| 20 | 1990 | 4 |
About P. Marpicati
P. Marpicati is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Dermatology and Cardiology and Cardiovascular Medicine, having authored 36 papers that have together received 290 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), Colorectal Cancer Treatments and Studies (10 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Breast Cancer Treatment Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Gastric Cancer Management and Outcomes (3 papers), Inflammatory mediators and NSAID effects (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Oncology (155 citations), Cancer Research (50 citations), Pulmonary and Respiratory Medicine (79 citations), Hepatology (18 citations) and Pathology and Forensic Medicine (34 citations). P. Marpicati has collaborated with scholars based in Italy and Poland. Frequent co-authors include Giovanni Marini, Edda Simoncini, Vittorio Ferrari, G. Rangoni, Lucia Vassalli, Vito Amoroso, Francesca Valcamonico, Alberto Zaniboni, Salvatore Grisanti and F Gorni. Their work appears in journals such as Journal of Clinical Oncology, Journal of Chemotherapy, Oncology, Cancer Chemotherapy and Pharmacology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.